...
search icon
nvcr-img

Novocure ltd share price

NVCR
NSQ
$18.2
+$0.96
(5.57%)
1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Novocure ltd analyst forecast

Novocure ltd share price chart

Novocure ltd key stock metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.01B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
4.84M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.98
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$9.82 L
$21.45 H
$18.2

About novocure ltd, common stock

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Novocure ltd financials

Dec '21Dec '22Dec '23Dec '24Dec '255YR TREND
Total Revenue535.03M537.84M509.34M605.22M655.35M[{"date":"2021-12-31","value":81.64,"profit":true},{"date":"2022-12-31","value":82.07,"profit":true},{"date":"2023-12-31","value":77.72,"profit":true},{"date":"2024-12-31","value":92.35,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Cost of Revenue114.88M114.87M128.28M137.18M166.88M[{"date":"2021-12-31","value":68.84,"profit":true},{"date":"2022-12-31","value":68.83,"profit":true},{"date":"2023-12-31","value":76.87,"profit":true},{"date":"2024-12-31","value":82.2,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Gross Profit420.15M422.97M381.06M468.04M488.47M[{"date":"2021-12-31","value":86.01,"profit":true},{"date":"2022-12-31","value":86.59,"profit":true},{"date":"2023-12-31","value":78.01,"profit":true},{"date":"2024-12-31","value":95.82,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Gross Margin78.53%78.64%74.81%77.33%74.54%[{"date":"2021-12-31","value":99.86,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":95.13,"profit":true},{"date":"2024-12-31","value":98.34,"profit":true},{"date":"2025-12-31","value":94.78,"profit":true}]
Operating Expenses464.49M512.50M614.67M638.53M642.27M[{"date":"2021-12-31","value":72.32,"profit":true},{"date":"2022-12-31","value":79.79,"profit":true},{"date":"2023-12-31","value":95.7,"profit":true},{"date":"2024-12-31","value":99.42,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]
Operating Income(44.33M)(89.52M)(232.87M)(170.50M)(153.80M)[{"date":"2021-12-31","value":-4433300000,"profit":false},{"date":"2022-12-31","value":-8952300000,"profit":false},{"date":"2023-12-31","value":-23287000000,"profit":false},{"date":"2024-12-31","value":-17049600000,"profit":false},{"date":"2025-12-31","value":-15380000000,"profit":false}]
Total Non-Operating Income/Expense(11.45M)18.88M83.06M79.39M39.42M[{"date":"2021-12-31","value":-13.79,"profit":false},{"date":"2022-12-31","value":22.73,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":95.58,"profit":true},{"date":"2025-12-31","value":47.46,"profit":true}]
Pre-Tax Income(52.08M)(81.85M)(191.74M)(131.16M)(136.25M)[{"date":"2021-12-31","value":-5207500000,"profit":false},{"date":"2022-12-31","value":-8184600000,"profit":false},{"date":"2023-12-31","value":-19174000000,"profit":false},{"date":"2024-12-31","value":-13116200000,"profit":false},{"date":"2025-12-31","value":-13625000000,"profit":false}]
Income Taxes6.28M10.69M15.30M37.47M(23.00K)[{"date":"2021-12-31","value":16.75,"profit":true},{"date":"2022-12-31","value":28.53,"profit":true},{"date":"2023-12-31","value":40.85,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":-0.06,"profit":false}]
Income After Taxes(58.35M)(92.53M)(207.04M)(168.63M)(136.23M)[{"date":"2021-12-31","value":-5835100000,"profit":false},{"date":"2022-12-31","value":-9253400000,"profit":false},{"date":"2023-12-31","value":-20704300000,"profit":false},{"date":"2024-12-31","value":-16862700000,"profit":false},{"date":"2025-12-31","value":-13622700000,"profit":false}]
Income From Continuous Operations(58.35M)(92.53M)(207.04M)(168.63M)(136.23M)[{"date":"2021-12-31","value":-5835100000,"profit":false},{"date":"2022-12-31","value":-9253400000,"profit":false},{"date":"2023-12-31","value":-20704300000,"profit":false},{"date":"2024-12-31","value":-16862700000,"profit":false},{"date":"2025-12-31","value":-13622700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income(58.35M)(92.53M)(207.04M)(168.63M)(136.23M)[{"date":"2021-12-31","value":-5835100000,"profit":false},{"date":"2022-12-31","value":-9253400000,"profit":false},{"date":"2023-12-31","value":-20704300000,"profit":false},{"date":"2024-12-31","value":-16862700000,"profit":false},{"date":"2025-12-31","value":-13622700000,"profit":false}]
EPS (Diluted)(0.56)(0.88)(1.95)(1.56)(1.22)[{"date":"2021-12-31","value":-56,"profit":false},{"date":"2022-12-31","value":-88,"profit":false},{"date":"2023-12-31","value":-195,"profit":false},{"date":"2024-12-31","value":-156,"profit":false},{"date":"2025-12-31","value":-122,"profit":false}]

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top